Big Move For POINT Biopharma Global Inc.
Tue, Oct 03, 2023 at 07:23 PM
POINT Biopharma Global Inc. (PNT:NASDAQ) soared at $12.36, representing a gain of 84.9%. On Tue, Oct 03, 2023, PNT:NASDAQ touched a New 2-Week High of $12.36. The stock appeared on our News Catalysts scanner on Tue, Oct 03, 2023 at 01:36 PM in the 'BIOTECH' category. From Tue, Sep 19, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
About POINT Biopharma Global Inc. (PNT:NASDAQ)
POINT Biopharma Global Inc is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer.
Top 10 Gainers:
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Vericity, Inc. (VERY:NASDAQ), 86.68%
- POINT Biopharma Global Inc. (PNT:NASDAQ), 84.89%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 56.13%
- SeaStar Medical Inc Com (ICU:NASDAQ), 41.49%
- Molekule Group Inc Com (MKUL:NASDAQ), 39.33%
- SciSparc Ltd. (SPRC:NASDAQ), 38.59%
- Fusion Pharmaceuticals Inc. (FUSN:NASDAQ), 34.73%
- Delta Apparel, Inc. (DLA:NYSEMKT), 30.2%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 30.17%